Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Shaw Christi had 4,194 Kyverna Therapeutics, Inc. shares withheld for tax (Form 4)
Traded May 27, 2026 · Filed May 29, 2026
On May 27, 2026, Shaw Christi (Director, Executive Chairperson) had 4,194 Kyverna Therapeutics, Inc. shares withheld for tax at US$8.59 for US$36,026, leaving 66,741 shares. Filed May 29, 2026 (Form 4).
- Withheld for tax
- 4,194 shares
- Price
- US$8.59
- Value
- US$36,026
- Holding after
- 66,741 shares
- Trading plan
- No
- Role
- Director, Executive Chairperson
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | Shares withheld for tax | 4,194 | US$8.59 | 66,741 | Direct |
Source
Related
- Kyverna Therapeutics, Inc.
- Shaw Christi
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Cohen Fred E · May 29, 2026